Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, today announced that it has been approved by the Connecticut Department of Consumer Protection to commence adult-use sales at its Stamford, Connecticut location, beginning Saturday, January 28 at 10:00 a.m. Curaleaf Stamford, located at 814 East Main St, is the Company’s first dispensary in the state to open its doors to adult-use customers.
Curaleaf currently serves medical patients at three other dispensaries across the state located in Hartford, Milford and Groton. The company anticipates welcoming adult-use customers at additional locations in the near future, pending regulatory approvals.
To celebrate the start of adult-use sales on January 28th, Curaleaf Stamford invites patients and customers for festivities throughout the day which will include vendor-sponsored giveaways, product discounts, music, and complimentary food and drinks. The dispensary’s wide array of cannabis goods includes Curaleaf whole flower, pre-rolls, edibles, topicals, tinctures, Select Elite vapes, and Curaleaf’s breakthrough vape hardware, Cliq by Select.
“Curaleaf is proud to be a part of Connecticut’s rapidly expanding adult-use market,” said Matt Darin, CEO of Curaleaf. “As we welcome new adult-use customers, I want to assure our medical patients that they will continue to be prioritized and receive the high quality of care they are accustomed to.”
At Curaleaf Stamford, existing medical patients will have priority access into the dispensary through a separate entrance, experience quicker check-ins with a dedicated staff, and will have a separate line for check-out. In addition, medical patients will continue to have access to Curaleaf’s Compassionate Care Plan, outstanding pharmacy team and patient consult rooms.